Compugen Ltd. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
51,485.00
74,240.00
81,847.00
61,527.00
30,438.00
45,675
Total Accounts Receivable
1,239.00
357.00
8,425.00
82.00
51.00
167
Other Current Assets
492.00
501.00
727.00
1,071.00
690.00
736
Total Current Assets
53,216.00
75,098.00
90,999.00
62,680.00
31,179.00
46,578
Net Property, Plant & Equipment
1,208.00
2,730.00
6,028.00
5,965.00
4,647.00
3,372
Total Investments and Advances
-
35,026.00
-
-
-
-
Other Assets
2,287.00
2,132.00
2,280.00
2,494.00
2,920.00
3,230
Total Assets
56,711.00
114,986.00
99,307.00
71,139.00
38,746.00
53,180
Accounts Payable
693.00
1,493.00
2,001.00
1,274.00
3,445.00
Other Current Liabilities
7,046.00
5,096.00
4,853.00
3,466.00
2,749.00
Total Current Liabilities
7,739.00
6,589.00
6,854.00
4,740.00
6,194.00
Provision for Risks & Charges
2,441.00
2,281.00
2,556.00
2,880.00
3,255.00
Other Liabilities
14,643.00
-
-
-
-
Total Liabilities
24,823.00
8,870.00
9,410.00
7,620.00
9,449.00
Common Equity (Total)
31,888.00
106,116.00
89,897.00
63,519.00
29,297.00
Total Shareholders' Equity
31,888.00
106,116.00
89,897.00
63,519.00
29,297.00
Total Equity
31,888.00
106,116.00
89,897.00
63,519.00
29,297.00
Liabilities & Shareholders' Equity
56,711.00
114,986.00
99,307.00
71,139.00
38,746.00

About Compugen

View Profile
Address
Azrieli Center
Holon TA 58858
Israel
Employees -
Website http://www.cgen.com
Updated 07/08/2019
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.